Chang C C, Huang C N, Chuang L M
Department of Internal Medicine, National Taiwan University, Taipei.
Eur J Endocrinol. 1998 Jul;139(1):44-8. doi: 10.1530/eje.0.1390044.
Type 1 diabetes mellitus is frequently associated with autoimmune thyroid disease (ATD). Genetic susceptibility to autoantibody formation in association with ATD and type 1 diabetes mellitus has been described with varying frequencies, but there is still debate about the situation in the Chinese population. We have, therefore, investigated the prevalence of anti-thyroid peroxidase (anti-TPO) in type 1 diabetic patients, and compared the effect of anti-glutamate decarboxylase (anti-GAD) on the thyroid autoimmunity in patients with type 1 diabetes mellitus in Taiwan.
Two hundred and forty-three subjects with type 1 diabetes mellitus and seventy unrelated normal controls were recruited for the detection of anti-TPO. Two hundred and seventeen sera from two hundred and forty-three type 1 diabetic patients were tested for anti-GAD. RIA and immunoprecipitation were used for anti-TPO and anti-GAD detection respectively.
The intra-assay and interassay coefficients of variation of anti-TPO detected by the RIA method ranged from 5.5% to 11.1%. Among 243 type 1 diabetic patients, 53 (21.8%) were positive for anti-TPO. Compared with those without thyroid autoimmunity, there was a female preponderance for the type 1 diabetic patients with thyroid autoimmunity (female:male, 99:91 vs 37:16 respectively). Among the type 1 diabetic patients with thyroid autoimmunity, anti-TPO tended to occur in those of older age or with long-standing disease. The frequency of anti-GAD was 45.6%, (99 of 217), without gender preponderance (males:females, 18.0% vs 27.61%). Compared with those with negative anti-GAD, no significant difference of anti-TPO positivity for the type 1 diabetic patients with positive anti-GAD was found.
Our data indicated that the RIA method for anti-TPO detection is sensitive and precise for routine clinical use. The presence of anti-TPO in 21.8% of our type 1 diabetic patients confirmed the strong association of ATD and type 1 diabetes mellitus without ethnic differences. The absence of correlation between anti-TPO and anti-GAD in our type 1 diabetic patients suggested genetic heterogeneity in the role of autoimmunity of type 1 diabetes mellitus and ATD among races.
1型糖尿病常与自身免疫性甲状腺疾病(ATD)相关。与ATD和1型糖尿病相关的自身抗体形成的遗传易感性已有不同频率的报道,但中国人群的情况仍存在争议。因此,我们调查了1型糖尿病患者中抗甲状腺过氧化物酶(抗-TPO)的患病率,并比较了抗谷氨酸脱羧酶(抗-GAD)对台湾1型糖尿病患者甲状腺自身免疫的影响。
招募243例1型糖尿病患者和70例无关的正常对照进行抗-TPO检测。对243例1型糖尿病患者中的217份血清进行抗-GAD检测。分别采用放射免疫分析(RIA)和免疫沉淀法检测抗-TPO和抗-GAD。
RIA法检测抗-TPO的批内和批间变异系数在5.5%至11.1%之间。在243例1型糖尿病患者中,53例(21.8%)抗-TPO呈阳性。与无甲状腺自身免疫的患者相比,有甲状腺自身免疫的1型糖尿病患者女性居多(女性:男性分别为99:91和37:16)。在有甲状腺自身免疫的1型糖尿病患者中,抗-TPO倾向于出现在年龄较大或病程较长的患者中。抗-GAD的频率为45.6%(217例中有99例),无性别差异(男性:女性分别为18.0%和27.61%)。与抗-GAD阴性的患者相比,抗-GAD阳性的1型糖尿病患者抗-TPO阳性率无显著差异。
我们的数据表明,RIA法检测抗-TPO对常规临床应用敏感且精确。我们的1型糖尿病患者中有21.8%存在抗-TPO,证实了ATD与1型糖尿病之间存在密切关联,且无种族差异。我们的1型糖尿病患者中抗-TPO与抗-GAD之间无相关性,提示不同种族中1型糖尿病和ATD自身免疫作用存在遗传异质性。